Showing results (1-10 of 240) with videos related to
Sort By:
Pageof 24
Journal of Cellular and Molecular Medicine|April 6, 2026
Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTACDaniela Cilloni, Alessandro Ferrando, Francesco FrassoniCurrent Opinion in Drug Discovery & Development|September 3, 2010
Emerging targets for hematological malignanciesDaniela Cilloni, Francesco Frassoni, Giuseppe SaglioJournal of Clinical Medicine|February 13, 2026
Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient MonitoringAlessandro Ferrando, Valentina Bonuomo, Arianna Savi, et al.Scientific Reports|July 19, 2019
Discrete Changes in Glucose Metabolism Define AgingSilvia Ravera, Marina Podestà, Federica Sabatini, et al.Journal of Clinical Medicine|January 25, 2025
Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem CellsSimone Rocco, Alessandro Maglione, Valentina Schiavo, et al.BMC Cancer|July 20, 2013
Design and application of a novel PNA probe for the detection at single cell level of JAK2V617F mutation in Myeloproliferative NeoplasmsEnrico Bracco, Valentina Rosso, Anna Serra, et al.Seminars in Hematology|June 5, 2003
Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapyDaniela Cilloni, Giuseppe SaglioActa Haematologica|June 5, 2004
WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndromeDaniela Cilloni, Giuseppe SaglioClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Molecular pathways: BCR-ABLDaniela Cilloni, Giuseppe SaglioBest Practice & Research. Clinical Haematology|December 5, 2009
CML: a model for targeted therapyDaniela Cilloni, Giuseppe SaglioPageof 24